Live Breaking News & Updates on Verona Pharma Plc|Page 5

Stay updated with breaking news from Verona pharma plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Verona Pharma to Present at H.C. Wainwright 24th Annual

LONDON and RALEIGH, N.C., Aug. 29, 2022 (GLOBE NEWSWIRE) Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces that senior. ....

City Of , United Kingdom , Verona Pharma , Annual Global Investment Conference , Nasdaq Vrna , Verona Pharma Plc ,

Verona Pharma strengthens commercialization leadership

LONDON and RALEIGH, N.C., Aug. 24, 2022 (GLOBE NEWSWIRE) Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage. ....

United Kingdom , City Of , Kimberly Minarovich Michael Barron , Matthew Casbon , Verona Pharma , Matthew Rysavy , Chris Martin , Drug Administration , Iowa State University , Salix Pharmaceuticals , Marketing At Salix Pharmaceuticals , Biodelivery Sciences International , Circassia Pharmaceuticals , Cystic Fibrosis Franchise At Solvay Pharmaceuticals , Abbott Laboratories , Global Research Sales , Valeant Pharmaceuticals , Chester University , Vice President , Market Access , Senior Vice President , New Drug Application , Chief Business Officer , Global Strategic Marketing , Global Research , Associate Vice President ,

Verona Pharma plc Announces Pricing of Upsized Underwritten

LONDON and RALEIGH, N.C., Aug. 10, 2022 (GLOBE NEWSWIRE) Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage. ....

New York , United States , United Kingdom , City Of , Wedbush Pacgrow , Kimberly Minarovich Michael Barron , Verona Pharma , International Media , Financial Services , Truist Securities Inc , Exchange Commission , While The Company , Strategic Communications , Prospectus Department , Equity Syndicate Prospectus Department , European Union Withdrawal , Piper Sandler Co , Hc Wainwright Co , Depositary Shares , Piper Sandler , Truist Securities , Annual Report , European Union , Kingdom Prospectus , European Economic Area , United Kingdom Prospectus Regulation ,

Recent Research Analysts' Ratings Updates for Verona Pharma (VRNA)

Verona Pharma (NASDAQ: VRNA) has recently received a number of price target changes and ratings updates: 3/30/2022 – Verona Pharma was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $5.50 price target on the stock. According to Zacks, “Verona Pharma plc is a clinical-stage […] ....

New Zealand General , New Zealand , United States , United Kingdom , City Of , David Zaccardelli , Verona Pharma , Verona Pharma Plc , A Davidson , Securities Exchange Commission , Zacks Investment Research , Da Davidson , Wellington Management Group , Citadel Advisors , Citigroup Inc , Millennium Management , Exchange Commission , Management Group , Pharma Plc , Nasdaq Vrna ,

Verona Pharma plc (NASDAQ:VRNA) Short Interest Down 33.6% in March

Verona Pharma plc (NASDAQ:VRNA – Get Rating) saw a large decrease in short interest in March. As of March 15th, there was short interest totalling 57,400 shares, a decrease of 33.6% from the February 28th total of 86,400 shares. Based on an average daily volume of 75,000 shares, the short-interest ratio is currently 0.8 days. […] ....

New Zealand General , New Zealand , David Zaccardelli , Verona Pharma , Verona Pharma Plc , A Davidson , Zacks Investment Research , Wellington Management Group , Da Davidson , Citadel Advisors , Citigroup Inc , Verona Pharma Company Profile Get Rating , Millennium Management , Get Rating , Management Group , Investment Research , Pharma Company Profile , Pharma Plc , Nasdaq Vrna ,